Drug-Layering Process Efficiency: Evaluation Studies

Introduction to Drug-Layering Process Efficiency

Drug-layering process efficiency shapes modern pharmaceutical production. It affects production speed, product cost, and product quality. Faster processing can cut expenses and boost output. However, the process must still meet high quality standards. Efficient operations deliver affordable, reliable medications that meet both industry and patient demands.

Factors Driving Process Efficiency

Drug-layering process efficiency depends on starter bead type, layering medium, and the API’s properties.

Role of Starter Bead Selection

Tests compared layering APIs on microcrystalline cellulose pellets, sugar beads, and tartaric acid spheres. The fastest results came from using organic solvent-based suspensions on 800–1000 μm starter beads. Smaller beads slowed the initial coating. Sticky APIs demanded careful handling to avoid pellet clumping.

Organic vs. Water-Based Drug-Layering Processes

Organic solvent-based suspensions worked faster than water-based methods. Yet they increased costs and required solvent disposal.

• Water-based processes moved slower due to longer drying times.
• Organic solvent-based methods achieved high speed with medium-sized beads.
• Dry powder layering also performed efficiently for specific bead types.

Case Study: Improving Large-Scale Drug-Layering Efficiency

An Indian generic Metoprolol Succinate production faced delays. The setup used 105 kg starter beads with 1708 kg of 18% drug-layering liquid. It produced 413 kg of coated beads after 38 hours, which equaled a 290% weight gain. By optimizing energy input and droplet size [1], process time could drop to 10–15 hours. This change would cut almost two-thirds of the original time.

Strategies for Low-Solubility APIs

For APIs with poor solubility, suspensions often work best by means of efficiency and process time. Increasing solid concentration from 20% w/w to 30% w/w reduced the drug-layering liquid needed. It also shortened the process time by about 33% (see figure) [2]. Matrix core pellets, which blend the API with excipients like cellulose and binders, can be processed using either batch or continuous methods. These approaches keep the API evenly distributed and improve consistency.

Conclusion: Maximizing Drug-Layering Process Efficiency

Select the right starter bead size, often 800–1000 μm, to improve speed. Raise solids concentration to reduce liquid use and shorten coating time. Match the layering method to the API’s physical and chemical profile. Finally, balance speed, cost, and environmental impact. When applied together, these strategies greatly increase drug-layering process efficiency.

References

[1] Grave A, Pöllinger N, Neuwirth M., 11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Granada, 2018.

[2] Internal Glatt documents of various years, which have not been released to the public.

This study was firstly published in: Pharm. Ind. 84, Nr. 12, 1440–1450 (2022), by author: Norbert Pöllinger, Glatt Pharmaceutical Services GmbH & Co. KG, Binzen/Germany.